New York A 5218: Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication

Status: REFERRED TO HEALTH (as of 2024-01-03)

State: New York · Session: 2023-2024 · Bill: A 5218

Sponsors: William A. Barclay, Brian Manktelow, Joe DeStefano, John Lemondes, Joseph Giglio, Kenneth Blankenbush

View New York A 5218 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.